Effekt af statiner på koronar endothelfunktion hos HIV-positive i antiretroviral behandling - HIV-Statin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-003184-23-DK

Enrollment

Registered

2005-07-20

Start date

2005-09-08

Completion date

Unknown

Last updated

2013-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-positiv i antiretroviral behandling

Interventions

Product Name: Pravastatin Product Code: Pravastatin Pharmaceutical Form: Tablet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Verificeret HIV • I antiretroviral behandling (min 3 år) • Alder =65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: • Alkohol misbrug. • Alder < 18 år. • Graviditet, laktation. • Kendt iskæmisk hjertesygdom • Diabetes mellitus • Kolesterolsænkende behandling • Klaustrofobi • Leversygdom • Nedsat nyrefunktion

Design outcomes

Primary

Measure	Time frame
Main Objective: At undersøge effekten af statiner på den globale myokardieperfusionsreserve (koronar endothelfunktion) hos hyperkolesterolæmiske og normokolesterolæmiske HIV-positive i antiretroviral behandling ved hjælp af PET og perifer endothelfunktion;Secondary Objective: ;Primary end point(s): PET-estimeret myokardieperfusionsreserve	—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026